Branden Sosa

Dr. Branden Sosa

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2023 in Nature
Verified
Journal Article
Closed access
PDF file
SBSeoyeon Bok
Seoyeon Bok
AYAlisha R. Yallowitz
Alisha R. Yallowitz
JSJun Sun
Jun Sun
JMJason McCormick
Jason McCormick
MCMichelle Cung
Michelle Cung
MGMatthew B. Greenblatt
Matthew B. Greenblatt

4 January 2024 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
MCMichelle Cung
Michelle Cung
BSBranden Sosa
Branden Sosa
HYHe S Yang
He S Yang
MMMichelle M McDonald
Michelle M McDonald
BMBrya G Matthews
Brya G Matthews
MGMatthew B Greenblatt
Matthew B Greenblatt
Artificial intelligence (AI) chatbots utilizing large language models (LLMs) have recently garnered significant interest due to their ability to generate humanlike responses to user inquiries in an interactive dialog format. While these models are being increasingly utilized to obtain medical information by patients, scientific and medical providers, and trainees to address biomedical questions, their performance may vary from field to field. The opportunities and risks these chatbots pose to the widespread understanding of skeletal health and science are unknown. Here we assess the performance of 3 high-profile LLM chatbots, Chat Generative Pre-Trained Transformer (ChatGPT) 4.0, BingAI, and Bard, to address 30 questions in 3 categories: basic and translational skeletal biology, clinical practitioner management of skeletal disorders, and patient queries to assess the accuracy and quality of the responses. Thirty questions in each of these categories were posed, and responses were independently graded for their degree of accuracy by four reviewers. While each of the chatbots was often able to provide relevant information about skeletal disorders, the quality and relevance of these responses varied widely, and ChatGPT 4.0 had the highest overall median score in each of the categories. Each of these chatbots displayed distinct limitations that included inconsistent, incomplete, or irrelevant responses, inappropriate utilization of lay sources in a professional context, a failure to take patient demographics or clinical context into account when providing recommendations, and an inability to consistently identify areas of uncertainty in the relevant literature. Careful consideration of both the opportunities and risks of current AI chatbots is needed to formulate guidelines for best practices for their use as source of information about skeletal health and biology.

1 July 2021 in The Bone & Joint Journal
Verified
Journal Article
Closed access
PDF file
EKEmile-Victor Kuyl
Emile-Victor Kuyl
FSFei Shu
Fei Shu
BSBranden Sosa
Branden Sosa
JLJuan D. Lopez
Juan D. Lopez
DQDi Qin
Di Qin
XYXu Yang
Xu Yang
Aims: Aseptic loosening is a leading cause of uncemented arthroplasty failure, often accompanied by fibrotic tissue at the bone-implant interface. A biological target, neutrophil extracellular traps (NETs), was investigated as a crucial connection between the innate immune system’s response to injury, fibrotic tissue development, and proper bone healing. Prevalence of NETs in peri-implant fibrotic tissue from aseptic loosening patients was assessed. A murine model of osseointegration failure was used to test the hypothesis that inhibition (through Pad4-/- mice that display defects in peptidyl arginine deiminase 4 (PAD4), an essential protein required for NETs) or resolution (via DNase 1 treatment, an enzyme that degrades the cytotoxic DNA matrix) of NETs can prevent osseointegration failure and formation of peri-implant fibrotic tissue. Methods: Patient peri-implant fibrotic tissue was analyzed for NETs biomarkers. To enhance osseointegration in loose implant conditions, an innate immune system pathway (NETs) was either inhibited ( Pad4-/- mice) or resolved with a pharmacological agent (DNase 1) in a murine model of osseointegration failure. Results: NETs biomarkers were identified in peri-implant fibrotic tissue collected from aseptic loosening patients and at the bone-implant interface in a murine model of osseointegration failure. Inhibition ( Pad4-/- ) or resolution (DNase 1) of NETs improved osseointegration and reduced fibrotic tissue despite loose implant conditions in mice. Conclusion: This study identifies a biological target (NETs) for potential noninvasive treatments of aseptic loosening by discovering a novel connection between the innate immune system and post-injury bone remodelling caused by implant loosening. By inhibiting or resolving NETs in an osseointegration failure murine model, fibrotic tissue encapsulation around an implant is reduced and osseointegration is enhanced, despite loose implant conditions. Cite this article: Bone Joint J 2021;103-B(7 Supple B):135–144.

26 February 2021 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
AVAlexander Vesprey
Alexander Vesprey
ESEun Sung Suh
Eun Sung Suh
DADidem Göz Aytürk
Didem Göz Aytürk
XYXu Yang
Xu Yang
MRMiracle Rogers
Miracle Rogers
UAUgur M. Ayturk
Ugur M. Ayturk
Metal implants are commonly used in orthopaedic surgery. The mechanical stability and longevity of implants depend on adequate bone deposition along the implant surface. The cellular and molecular mechanisms underlying peri‐implant bone formation (i.e. osseointegration) are incompletely understood. Herein, our goal was to determine the specific bone marrow stromal cell populations that contribute to bone formation around metal implants. To do this, we utilized a mouse tibial implant model that is clinically representative of human joint replacement procedures. Using a lineage‐tracing approach, we found that both Acta2.creERT2‐ and Tmem100.creERT2‐ lineage cells are involved in peri‐implant bone formation, and Pdgfra‐ and Ly6a/Sca1‐expressing stromal cells (PαS cells) are highly enriched in both lineages. Single cell RNA‐seq analysis indicated that PαS cells are quiescent in uninjured bone tissue; however, they express markers of proliferation and osteogenic differentiation shortly after implantation surgery. Our findings indicate that PαS cells are mobilized to repair bone tissue and participate in implant osseointegration following surgery. Biologic therapies targeting PαS cells might improve osseointegration in patients undergoing orthopaedic procedures.

1 May 2022 in Bone & Joint Research
Verified
Journal Article
Open access
KSKevin Staats
Kevin Staats
BSBranden Sosa
Branden Sosa
EKEmile-Victor Kuyl
Emile-Victor Kuyl
FWFei Wang
Fei Wang
VSVincentius Suhardi
Vincentius Suhardi
XYXu Yang
Xu Yang
Aims: To develop an early implant instability murine model and explore the use of intermittent parathyroid hormone (iPTH) treatment for initially unstable implants. Methods: 3D-printed titanium implants were inserted into an oversized drill-hole in the tibiae of C57Bl/6 mice (n = 54). After implantation, the mice were randomly divided into three treatment groups (phosphate buffered saline (PBS)-control, iPTH, and delayed iPTH). Radiological analysis, micro-CT (µCT), and biomechanical pull-out testing were performed to assess implant loosening, bone formation, and osseointegration. Peri-implant tissue formation and cellular composition were evaluated by histology. Results: iPTH reduced radiological signs of loosening and led to an increase in peri-implant bone formation over the course of four weeks (timepoints: one week, two weeks, and four weeks). Observational histological analysis shows that iPTH prohibits the progression of fibrosis. Delaying iPTH treatment until after onset of peri-implant fibrosis still resulted in enhanced osseointegration and implant stability. Despite initial instability, iPTH increased the mean pull-out strength of the implant from 8.41 N (SD 8.15) in the PBS-control group to 21.49 N (SD 10.45) and 23.68 N (SD 8.99) in the immediate and delayed iPTH groups, respectively. Immediate and delayed iPTH increased mean peri-implant bone volume fraction (BV/TV) to 0.46 (SD 0.07) and 0.34 (SD 0.10), respectively, compared to PBS-control mean BV/TV of 0.23 (SD 0.03) (PBS-control vs immediate iPTH, p < 0.001; PBS-control vs delayed iPTH, p = 0.048; immediate iPTH vs delayed iPTH, p = 0.111). Conclusion: iPTH treatment mediated successful osseointegration and increased bone mechanical strength, despite initial implant instability. Clinically, this suggests that initially unstable implants may be osseointegrated with iPTH treatment. Cite this article: Bone Joint Res 2022;11(5):260–269.

21 June 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
JYJonathan S. Yu
Jonathan S. Yu
LSLeonardo Sanchez
Leonardo Sanchez
Jacob ZeitlinJacob Zeitlin
Jacob Zeitlin
BSBranden Sosa
Branden Sosa
PSPeter Sculco
Peter Sculco
APAjay Premkumar
Ajay Premkumar